This paper analyzes the unreasonable intravenous prescriptions intercepted by our hospital's prescription審核system, and promotes software optimization and clinical rational drug use.
This document is an academic research paper published in the journal 'Northern Pharmacy' (北方药学). It presents a study conducted at the First Affiliated Hospital of Xiamen University, focusing on the analysis of intravenous medication prescriptions that were flagged as 'Level 6' (unreasonable) by the hospital's prescription review software.
The study collected 938 cases of intercepted prescriptions from January to June 2018. The results indicate that the most common error was the improper selection of solvents (35.39%), followed by inappropriate dosage and usage methods (20.26%). The paper details specific examples of these errors, including drug incompatibilities, inappropriate drug selection for skin infections, and off-label use of Gentamicin for pediatric diarrhea. The authors conclude with recommendations for strengthening physician training and optimizing the prescription review system to promote rational drug use. This manual is written in Chinese.
The study categorized errors into improper solvent selection (35.39%), inappropriate dosage and usage (20.26%), drug incompatibilities (17.16%), off-label use (12.90%), and others.
According to the study, 35.39% of the intercepted prescriptions involved the improper selection of solvents.
The text notes an incompatibility between Sodium Cefotazone Pentahydrate and Ambrisoline Hydrochloride Injection, which can cause white turbidity due to pH and solvent effects.